MDT

101.45

+0.95%↑

A

138.61

-0.74%↓

VEEV

225

+2.37%↑

HQY

86.43

+2.1%↑

NEOG

9.92

+0.61%↑

MDT

101.45

+0.95%↑

A

138.61

-0.74%↓

VEEV

225

+2.37%↑

HQY

86.43

+2.1%↑

NEOG

9.92

+0.61%↑

MDT

101.45

+0.95%↑

A

138.61

-0.74%↓

VEEV

225

+2.37%↑

HQY

86.43

+2.1%↑

NEOG

9.92

+0.61%↑

MDT

101.45

+0.95%↑

A

138.61

-0.74%↓

VEEV

225

+2.37%↑

HQY

86.43

+2.1%↑

NEOG

9.92

+0.61%↑

MDT

101.45

+0.95%↑

A

138.61

-0.74%↓

VEEV

225

+2.37%↑

HQY

86.43

+2.1%↑

NEOG

9.92

+0.61%↑

Strona główna・Stock List・Seres Therapeutics Inc

Search

Seres Therapeutics Inc

Closed

SectorHealthcare

15.29 3.17

Overview

Share price change

24h

Current

Min

14.87

Max

15.71

Key metrics
By Trading Economics
Income	28M 8.2M
Sales	351K 351K
P/E Sector Avg	18.136 89.037
EPS	0.94
Profit margin	2,337.322
Employees	103
EBITDA	28M 9.3M

Recommendations
By TipRanks
Recommendations	Buy
12 Months Forecast	+46.18% upside

Dividends
By Dow Jones
Next Earnings	12 mar 2026

Market Stats
By TradingEconomics
Market Cap	11M 144M
Previous open	12.12
Previous close	15.29

News Sentiment

By Acuity

25%

75%

56 / 360 Ranking in Healthcare

Technical Score

By Trading Central

Confidence

Bearish Evidence

N/A / 9.31 Support & Resistance

Seres Therapeutics Inc Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

22 sty 2026, 21:55 UTC

Earnings

Capital One Financial Posts Higher 4Q Profit As Lending Increases

22 sty 2026, 23:52 UTC

Earnings

Intel Returns to Losses as Supply Shortages, Spending Weigh on Q4 Results and Forecast -- Update

22 sty 2026, 23:48 UTC

Market Talk

Nikkei May Rise as Tensions Between U.S. and Europe Ease -- Market Talk

22 sty 2026, 23:42 UTC

Market Talk

Gold Edges Lower on Possible Profit-Taking -- Market Talk

22 sty 2026, 23:40 UTC

Market Talk

Spark NZ's Market Share Loss Concerns Bear -- Market Talk

22 sty 2026, 23:30 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

22 sty 2026, 23:30 UTC

Market Talk

Genesis Energy Can Beat Newly Upgraded Earnings Goal -- Market Talk

22 sty 2026, 22:37 UTC

Market Talk

Acquisitions, Mergers, Takeovers

Capital One CEO: Brex Buy Reflects Business Payments Focus -- Market Talk

22 sty 2026, 21:59 UTC

Acquisitions, Mergers, Takeovers

Capital One Strikes $5.15 Billion Deal for Fintech Brex -- Update

22 sty 2026, 21:50 UTC

Market Talk

Acquisitions, Mergers, Takeovers

Tech, Media & Telecom Roundup: Market Talk

22 sty 2026, 21:44 UTC

Earnings

Self-Driving Stock Mobileye Plunged After Earnings. Here's Why. -- Barrons.com

22 sty 2026, 21:32 UTC

Acquisitions, Mergers, Takeovers

Capital One: Brex Invented Integrated Combination of Corporate Credit Cards, Spend Management Software and Banking in Single Platform >COF

22 sty 2026, 21:31 UTC

Acquisitions, Mergers, Takeovers

Capital One: Brex Is a Modern, AI-native Software Platform Offering Intelligent Finance Solutions >COF

22 sty 2026, 21:31 UTC

Acquisitions, Mergers, Takeovers

Capital One: Franceschi Will Continue to Lead Brex as Part of Capital One >COF

22 sty 2026, 21:30 UTC

Acquisitions, Mergers, Takeovers

Capital One to Acquire Brex in Combination of Stk and Cash Transaction Valued at $5.15 B >COF

22 sty 2026, 21:30 UTC

Earnings

Intel Returns to Losses as Supply Shortages, Spending Weigh on Q4 Results -- WSJ

22 sty 2026, 21:30 UTC

Acquisitions, Mergers, Takeovers

Capital One To Acquire Brex >COF

22 sty 2026, 21:13 UTC

Earnings

Intel Returns to Losses in Q4 as It Ramps Up Spending on Chip Production -- WSJ

22 sty 2026, 21:11 UTC

Earnings

Intuitive Surgical Sees 2026 Impact From Tariffs 1.2% of Revenue, Plus or Minus 10 Basis Points >ISRG

22 sty 2026, 21:11 UTC

Earnings

Intuitive Surgical Sees 2026 Adjusted Gross Profit Margin 67%-68% >ISRG

22 sty 2026, 21:10 UTC

Earnings

Intuitive Surgical Sees 2026 Worldwide Da Vinci Procedure Growth of 13%-15% >ISRG

22 sty 2026, 21:06 UTC

Earnings

Capital One 4Q Total Non-Interest Expense Increased 13% to $9.3B >COF

22 sty 2026, 21:05 UTC

Earnings

Capital One 4Q Provision for Credit Losses Increased $4.1B >COF

22 sty 2026, 21:05 UTC

Earnings

Capital One 4Q Rev $15.58B >COF

22 sty 2026, 21:05 UTC

Earnings

Capital One 4Q EPS $3.26 >COF

22 sty 2026, 21:05 UTC

Earnings

Capital One 4Q Net Interest Margin 8.26% >COF

22 sty 2026, 21:05 UTC

Earnings

Capital One 4Q Net $2.13B >COF

22 sty 2026, 21:05 UTC

Earnings

Capital One 4Q Adj EPS $3.86 >COF

22 sty 2026, 21:05 UTC

Earnings

Capital One 4Q Net Charge-Offs $3.8B >COF

22 sty 2026, 21:05 UTC

Earnings

Intuitive Surgical 4Q EPS $2.21 >ISRG

Peer Comparison

Price change

Seres Therapeutics Inc Forecast

Price Target

By TipRanks

46.18% upside

12 Months Forecast

Average 22 USD 46.18%

High 22 USD

Low 22 USD

Based on 2 Wall Street analysts offering 12 month price targets forSeres Therapeutics Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

2 ratings

2

Buy

0

Hold

0

Sell

Based on 2 analysts giving stock ratings to Seres Therapeutics Inc - Dist in the past 3 months.

Technical Score

By Trading Central

N/A / 9.31Support & Resistance

Recent bearish events outweigh bullish events.

All events are bearish.

All events are bearish.

Sentiment

By Acuity

56 / 360 Ranking in Healthcare

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

Other stocks from the sector

MDT

Medtronic PLC

101.45

A

Agilent Technologies Inc

138.61

VEEV

Veeva Systems Inc

225

HQY

HealthEquity Inc

86.43

NEOG

Neogen Corp

9.92

Live chat